Morgan Stanley 13D and 13G filings for Evofem Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-09-10 4:36 pm Sale | 2021-08-31 | 13G | Evofem Biosciences, Inc. EVFM | MORGAN STANLEY MS | 105 0.100% | -3,965 (-97.42%) | Filing |
| 2021-06-04 4:29 pm Purchase | 2021-05-25 | 13G | Evofem Biosciences, Inc. EVFM | MORGAN STANLEY MS | 4,070 5.100% | 4,070 (New Position) | Filing |